This program includes digital tools and medication management support for members prescribed GLP-1 drugs
Myocardial infarction and stroke are responsible for 75% of all death in patients with diabetes, who present a 2-4 increased incidence of death from coronary artery disease
Therefore, recent guidelines recommend GLP-1 RAs for patients with T2DM, established or high-risk atherosclerotic cardiovascular disease, and/or chronic kidney disease for glycemic management and comprehensive cardiovascular risk reduction [6,7]
In fact, the evidence shows that the type of supported rapid weight loss delivered by the Allurion Programme can be a more effective and healthy approach to weight management than a gradual weight-loss approach that is seen with GLP-1s
The decline in glomerular filtration rate also activates compensatory mechanisms, including the RAAS, the sympathetic nervous system, and the calcium-parathyroid axis, all of which have adverse effects on the cardiovascular system [53]
Hippocampal GLP1 receptors influence food intake, meal size, and effortbased responding for food through volume transmission